• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

1,645
107
73
69
69

COUNTRY

68
21
17
11
10

CATEGORIES

  • 576
  • 122
  • 558
  • 80
  • 530
  • 43
  • 507
  • 17
  • 19
  • 25

PRICE

813
1,113
1,311
2,779

PUBLISHED

167
274
672
2,779

PRODUCT TYPE

2,204
495
68
7
2
1
1
1

Oncology

The American Cancer Society forecasts that 1,638,910 new cancer cases will occur in the United States in 2012. As cancer rates worldwide are increasing, the oncological sector of the pharmaceutical industry is growing fast and it will continue to provide business opportunities in the next years. However, cancer trials are some of the most complex, time consuming and expensive across all therapeutic areas. What are the new paths to success in this lucrative but challenging market?

Find out the answer in the reports, books, and subscriptions listed under Research and Markets’ Oncology category. Our top-quality publications from industry experts cover every aspect of cancer drug therapy, with a focus on: Lung Cancer, Breast Cancer, Prostate Cancer, Leukaemia, Lymphoma, Ovarian Cancer, Colon Cancer, Cervical Cancer, Brain Cancer and Bladder Cancer. So read on for the latest clinical trials, pipeline reviews, industry news, and commercial opportunities.

Key players featured in our publications include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis, Wyeth, and many more. Show Less
Read more

PRODUCT TITLE

Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014

Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014" provides data on the Non-Small...

March 2014
FROM

Neuroendocrine Cancer Global Clinical Trials Review, H1, 2014

Neuroendocrine Cancer Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Neuroendocrine Cancer Global Clinical Trials Review, H1, 2014" provides data on the Neuroendocrine...

March 2014
FROM

Low-Grade Glioma Global Clinical Trials Review, H1, 2014

Low-Grade Glioma Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Low-Grade Glioma Global Clinical Trials Review, H1, 2014" provides data on the Low-Grade Glioma clinical...

March 2014
FROM

Malignant Glioma Global Clinical Trials Review, H1, 2014

Malignant Glioma Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Malignant Glioma Global Clinical Trials Review, H1, 2014" provides data on the Malignant Glioma clinical...

March 2014
FROM

THERAPEUTIC REVOLUTION The History of Medical Oncology from Early Days to the Creation of the Subspecialty

Cancer is a disease responsible for several million annual deaths among humans, worldwide However, advances in healthcare - which include breakthroughs in science and medicine as well as access to medical...

March 2014
Colon Carcinoma - Pipeline Review, H1 2014 Colon Carcinoma - Pipeline Review, H1 2014 - Product Thumbnail Image

Colon Carcinoma - Pipeline Review, H1 2014

Colon Carcinoma - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Colon Carcinoma - Pipeline Review, H1 2014’, provides an overview of the Colon Carcinoma’s therapeutic pipeline. This...

March 2014
FROM

Neuroblastoma Global Clinical Trials Review, H1, 2014

Neuroblastoma Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Neuroblastoma Global Clinical Trials Review, H1, 2014" provides data on the Neuroblastoma clinical trial scenario....

March 2014
FROM

Germinomatous (Seminomatous) Germ Cell Tumors Global Clinical Trials Review, H1, 2014

Germinomatous (Seminomatous) Germ Cell Tumors Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Germinomatous (Seminomatous) Germ Cell Tumors Global Clinical Trials Review,...

March 2014
FROM

Meningioma Global Clinical Trials Review, H1, 2014

Meningioma Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Meningioma Global Clinical Trials Review, H1, 2014" provides data on the Meningioma clinical trial scenario....

March 2014
FROM

Gastroesophageal (GE) Junction Carcinomas Global Clinical Trials Review, H1, 2014

Gastroesophageal (GE) Junction Carcinomas Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Gastroesophageal (GE) Junction Carcinomas Global Clinical Trials Review, H1, 2014"...

March 2014
FROM

Penile Cancer Global Clinical Trials Review, H1, 2014

Penile Cancer Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Penile Cancer Global Clinical Trials Review, H1, 2014" provides data on the Penile Cancer clinical trial scenario....

March 2014
FROM

Cholangiocellular Hepatoma Global Clinical Trials Review, H1, 2014

Cholangiocellular Hepatoma Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Cholangiocellular Hepatoma Global Clinical Trials Review, H1, 2014" provides data on the Cholangiocellular...

March 2014
FROM

Hormone-Sensitive Prostate Cancer Global Clinical Trials Review, H1, 2014

Hormone-Sensitive Prostate Cancer Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Hormone-Sensitive Prostate Cancer Global Clinical Trials Review, H1, 2014" provides data...

March 2014
FROM

Malignant Mesothelioma Global Clinical Trials Review, H1, 2014

Malignant Mesothelioma Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Malignant Mesothelioma Global Clinical Trials Review, H1, 2014" provides data on the Malignant Mesothelioma...

March 2014
FROM

Nasopharyngeal Cancer Global Clinical Trials Review, H1, 2014

Nasopharyngeal Cancer Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Nasopharyngeal Cancer Global Clinical Trials Review, H1, 2014" provides data on the Nasopharyngeal...

March 2014
FROM

Chemotherapy Induced Pain Global Clinical Trials Review, H1, 2014

Chemotherapy Induced Pain Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Chemotherapy Induced Pain Global Clinical Trials Review, H1, 2014" provides data on the Chemotherapy...

March 2014
FROM

OpportunityAnalyzer: Pancreatic Cancer - Opportunity Analysis and Forecasts to 2017

OpportunityAnalyzer: Pancreatic Cancer - Opportunity Analysis and Forecasts to 2017 Summary With five-year survival only approximately 5%, pancreatic cancer is characterized as a disease with some...

March 2014
FROM
Analytical Tool - Colorectal Cancer Analytical Tool - Colorectal Cancer - Product Thumbnail Image

Analytical Tool - Colorectal Cancer

"Analytical Tool - Colorectal Cancer" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in colorectal cancer R&D and business development It is at the same...

March 2014
Peptides in Oncology Drug Pipeline Update 2014 Peptides in Oncology Drug Pipeline Update 2014 - Product Thumbnail Image

Peptides in Oncology Drug Pipeline Update 2014

There are today 236 companies plus partners developing 226 peptide drugs in 579 developmental projects in cancer. In addition, there are 4 suspended drugs and the accumulated number of ceased drugs...

March 2014
Oncology Drug Pathway Analyzer (Standard Version) Oncology Drug Pathway Analyzer (Standard Version) - Product Thumbnail Image

Oncology Drug Pathway Analyzer (Standard Version)

EXTRA: Free online updates for a year Get instant, interactive pathway modeling on more than 3,400 cancer drugs across more than 100 different cancer types. Drug targets and their pathways are the...

March 2014
Loading Indicator

Our Clients

Our clients' logos